First Manhattan’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-200
| Closed | -$13K | – | 1417 |
|
|
2019
Q3 | $13K | Hold |
200
| – | – | ﹤0.01% | 1128 |
|
|
2019
Q2 | $11K | Hold |
200
| – | – | ﹤0.01% | 1177 |
|
|
2019
Q1 | $14K | Hold |
200
| – | – | ﹤0.01% | 1169 |
|
|
2018
Q4 | $12K | Hold |
200
| – | – | ﹤0.01% | 1148 |
|
|
2018
Q3 | $14K | Buy |
+200
| New | +$11.7K | ﹤0.01% | 1185 |
|
|
2018
Q1 | – | Sell |
-110,900
| Closed | -$3.79M | – | 1504 |
|
|
2017
Q4 | $3.79M | Buy |
110,900
+40,900
| +58% | +$1.3M | 0.02% | 298 |
|
|
2017
Q3 | $2.25M | Hold |
70,000
| – | – | 0.01% | 351 |
|
|
2017
Q2 | $2.28M | Hold |
70,000
| – | – | 0.01% | 340 |
|
|
2017
Q1 | $2.2M | Buy |
70,000
+69,800
| +34,900% | +$2.06M | 0.01% | 340 |
|
|
2016
Q4 | $5K | Hold |
200
| – | – | ﹤0.01% | 1261 |
|
|
2016
Q3 | $5K | Hold |
200
| – | – | ﹤0.01% | 1271 |
|
|
2016
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 1325 |
|
|
2016
Q1 | $4K | Hold |
200
| – | – | ﹤0.01% | 1280 |
|
|
2015
Q4 | $7K | Hold |
200
| – | – | ﹤0.01% | 1230 |
|
|
2015
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 1291 |
|
|
2015
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 1298 |
|
|
2015
Q1 | $6K | Hold |
200
| – | – | ﹤0.01% | 1289 |
|
|
2014
Q4 | $6K | Hold |
200
| – | – | ﹤0.01% | 1313 |
|
|
2014
Q3 | $5K | Hold |
200
| – | – | ﹤0.01% | 1309 |
|
|
2014
Q2 | $5K | Buy |
+200
| New | +$5.32K | ﹤0.01% | 1286 |
|
First Manhattan's GHDX Position: Q4 2019 in Review
First Manhattan sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 200 shares — an estimated $13K sold.
First Manhattan first reported a position in GHDX in Q2 2014 and held it in 20 quarters. The position peaked at $3.79M in Q4 2017. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- First Manhattan reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- First Manhattan sold 200 Genomic Health, Inc. shares in Q4 2019, an estimated $13K.
- First Manhattan first reported a position in Genomic Health, Inc. in Q2 2014 and held it in 20 quarters.
- First Manhattan's Genomic Health, Inc. position peaked at $3.79M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on First Manhattan's 13F filing for Q4 2019, filed 13 Feb 2020.